Tucidinostat | Clinical Trials, Side Effects | AIDSinfo

Tucidinostat | Clinical Trials, Side Effects | AIDSinfo

Tucidinostat

 Other Names: CS-055, Chidamide, Epidaza, HBI-8000Drug Class: Latency-Reversing AgentsMolecular Formula: C22 H19 F N4 O2Registry Number: 1616493-44-7 (CAS)Chemical Name: Benzamide, N-(2-amino-4-fluorophenyl)-4-(((1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-Benzamide, N-(2-amino-4-fluorophenyl)-4-((((2E)-1-oxo-3-(3-pyridinyl)-2-propen-1-yl)amino)methyl)-Chemical Class: BenzamideOrganization: HUYA Bioscience International; Shenzhen Chipscreen Biosciences Ltd.Phase of Development: Tucidinostat is in Phase II/III development as a latency-reversing agent for HIV.

(Compound details obtained from ChemIDplus Advanced,1 HUYA Bioscience International website,2 and Treatment Action Group website3)